Announcements Trials
Browse Landscape

Phase

Phase NA 47Phase 2 7Phase 4 2Phase 2/3 2Phase 3 1Phase 1/2 1

Status

Completed 3Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 1NET 1Genitourinary 1Endocrine 1

Conditions

Breast Neoplasms 2768Carcinoma, Non-Small-Cell Lung 2267Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1050Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 819Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 754Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 685Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 599Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

epigallocatechin gallate 2Ascorbic Acid 2peflavit 1microcrystalline cellulose 1fisetin 1cabozantinib 1Temozolomide 1Quercetin 1Protons 1Photons 1Flavonoids 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Frailty × Clear all
NCT04553666 2026-05-07

ReFOCUS1

University of Rochester

Phase 2 Completed
24 enrolled 17 charts

Frailty, Inflammation

NCT04733534 2026-04-24

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
110 enrolled

Frailty, Neoplasms

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting
118 enrolled

Frailty, Inflammation

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting
46 enrolled
EndocrineNET

Frailty, Neuroendocrine Tumors

NCT04134390 2024-01-09

CABOMAYOR

Spanish Oncology Genito-Urinary Group

Phase 2 Completed
25 enrolled
Genitourinary

Frailty, Carcinoma, Renal Cell

NCT05548504 2022-09-21

HERAN2

Odense University Hospital

Phase 2 Not yet recruiting
182 enrolled
Thoracic

Frailty, Carcinoma, Non-Small-Cell Lung, Radiation Injuries

NCT02819011 2020-02-27

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Baylor College of Medicine

Phase 2 Completed
44 enrolled 16 charts

Frailty, Arthritis, Diabetes Mellitus, Neoplasms, Parkinson Disease, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡